The TUGETHER Clinical Trial - Maria Bodnar
Maria is a participant in the TUGETHER clinical trial, which is targeting HER2-positive metastatic breast cancer on multiple levels in an attempt to slow and arrest the progression of this disease.
Developed by Australian researchers, TUGETHER will combine the well-known anti-HER2 therapy Trastuzumab (Herceptin), which works to block the HER2 receptors on the outside of cancer cells, with a new anti-HER2 therapy called Tucatinib, which works by getting inside the cancer cells and blocking the growth signals sent by HER2 receptors. These two anti-HER2 therapies will be combined with Pembrolizumab, an immunotherapy that aids the body’s immune system to identify and kill cancer cells.
It is hoped that the combination of these therapies will provide a new treatment approach for metastatic HER2-positive breast cancer.
TUGHETHER will recruit 50 patients from 16 institutions across Australia.
----------------------------------------------------------------
Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand committed to exploring and finding better treatments for people affected by breast cancer through clinical trials research.
Please like this video then visit www.breastcancertrials.org.au to find out more about our current breast cancer clinical trials that may be suitable for you, and ways in which you can help support breast cancer research.
----------------------------------------------------------------
SUBSCRIBE TO OUR YOUTUBE CHANNEL
/ @breastcancertrials
LET'S CONNECT
Email ►[email protected]
Tel 1800 423 444
WWW ► http://www.breastcancertrials.org.au
Linkedin ► / 5057154
Twitter ► / bctrialsanz
Facebook ► / breastcancertrials
Instagram ► / breastcancertrials
![[SwordArtOnlineⅡ] Liberty Rosario ユウキ](https://images.videosashka.com/watch/enGw9E3TlA0)
